PIII
The table below shows P3 Health Partners's income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $1.46B | $1.50B | $1.27B | $1.05B | $578.60M | $491.06M |
| Cost of revenue | - | - | - | - | - | - |
| Gross profit | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - |
| SG&A | $106.31M |
P3 Health Partners reported annual revenue of $1.46B for fiscal year 2025. That is down 2.8% from $1.50B in fiscal 2024. Over the 7 fiscal years shown, annual revenue grew from $145.48M (FY 2019) to $1.46B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $112.60M |
| $122.36M |
| $157.28M |
| $22.75M |
| $53.39M |
| Operating income | -$270.30M | -$320.66M | -$167.93M | -$1.56B | -$22.75M | -$28.59M |
| Income tax | $2.02M | $4.39M | $2.69M | $1.86M | $0.00 | $0.00 |
| Net income | -$147.95M | -$135.85M | -$57.77M | -$270.13M | -$24.81M | -$31.41M |
| EPS (diluted) | -$45.26 | -$54.06 | -$0.63 | -$6.50 | - | - |